logo

For the Inventor, By the Inventor

Sandvika, Norway

Algipharma as


USPTO Granted Patents = 12

% Expired Patents = 8.3



Forward Citations = 25

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Arne Dessen (9 out of 11 patents)

silverMedal Rolf Myrvold (6 out of 10 patents)

bronzeMedal Philip Rye (5 out of 5 patents)

4.  Edvar Onsoyen (5 out of 5 patents)

5.  David Thomas (3 out of 5 patents)

6.  Timothy Rutland Walsh (3 out of 4 patents)

7.  Bildad Nyambura (1 out of 3 patents)

8.  Astrid Hilde Myrset (1 out of 1 patent)

9.  Paul Lewis (1 out of 2 patents)

10.  Edvar Onsøyen (1 out of 1 patent)

11.  Anand Bakle (1 out of 1 patent)

12.  Are Kristiansen (1 out of 1 patent)

13.  Stephen Hart (1 out of 1 patent)

14.  Aristides Tagalakis (1 out of 1 patent)

15.  Havard Sletta (4 patents)


12 patents:

1. 12649000 - Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers (2026-06-09),
2. 11992553 - Inhalable powder formulations of alginate oligomers (2024-05-28),
3. 11712448 - Use of alginate oligomers as blood anticoagulants (2023-08-01),
4. 11413306 - Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract (2022-08-16),
5. 11385174 - Method for the qualitative and quantitative detection of alginate oligomers in body fluids (2022-07-12),
6. 10751363 - Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunction (2020-08-25),
7. 10624920 - Use of alginate oligomers in combating biofilms (2020-04-21),
8. 9877983 - Use of alginate oligomers in combating biofilms (2018-01-30),
9. 9801901 - Alginate oligomers for use in overcoming multidrug resistance in bacteria (2017-10-31),
10. 9018158 - Alginate oligomers for use in overcoming multidrug resistance in bacteria (2015-04-28),
11. 8815831 - Treatment of Acinetobacter with alginate oligomers and antibiotics (2014-08-26),
12. 8680072 - Use of alginate oligomers in combating biofilms (2014-03-25),
Company Overview
Algipharma AS is a Norwegian company specializing in the development and manufacturing of innovative pharmaceutical products. The organization focuses on leveraging advanced biotechnological processes to create high-quality, sustainable solutions for the healthcare sector. With a strong emphasis on research and development, Algipharma is dedicated to enhancing therapeutic options and improving patient outcomes through its expertise in drug formulation and delivery systems. The company operates within a dynamic regulatory landscape, ensuring compliance and quality in all its offerings.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#2 in Sandvika

#143 in Norway

#48,129 in the World

Sandvika, NO
Sandvika, Norway

Algipharma as

Forward Citations = 25

16 inventors:

goldMedal Arne Dessen (9 out of 11 patents)

silverMedal Rolf Myrvold (6 out of 10 patents)

bronzeMedal Philip Rye (5 out of 5 patents)

4.  Edvar Onsoyen (5 out of 5 patents)

5.  David Thomas (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Algipharma as. Retrieved from https://idiyas.com/company/algipharma-as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…